OXFORD, England, & LOS ANGELES--(BUSINESS WIRE)--Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, and Plasmidsaurus, the LA-based ...

What is Nanopore DNA Sequencing? Nanopore DNA sequencing is a cutting-edge technology that enables the direct, real-time analysis of long DNA or RNA fragments. Unlike conventional sequencing methods ...

A pioneering partnership between researchers from The Grainger College of Engineering at the University of Illinois Urbana-Champaign has produced a novel nanopore sensing platform for ...

The sequencing of the human genome has been a scientific landmark achievement, and it has had major implications for our understanding of human health 1. However, excluding contributing factors from ...

"As complex living systems, we likely have trillions upon trillions of tiny nanoscopic holes in our cells that facilitate and regulate the crucial processes that keep us alive and make up who are," ...

OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies (Oxford Nanopore) has announced a landmark project with Singapore's National Precision Medicine (NPM) programme, led by Precision Health ...

Cell and gene therapies are rapidly becoming a staple of the therapeutic landscape for a range of diseases. Recent improvements in the accuracy, read length, and throughput offered by Oxford Nanopore ...

Funding from agencies such as the National Science Foundation, the National Institutes of Health, NASA and many more help ensure the United States remains at the forefront of discoveries in health, ...

During cancer development, from incipient neoplastic cells to late-stage disease, pathological organs and cells release specific molecules, proteins or nucleic acids—commonly referred to as cancer ...

The first DNA sequencing was performed by Sanger and co-workers in the 1970s, using a method based on the attenuation of the growing nucleotide chain with dideoxythymidine triphosphate (ddTTP). The ...

Oxford Nanopore Technologies and Lonza announced the launch of a new technology approach designed to modernize and accelerate GMP quality control testing for mRNA therapeutics. The solution combines ...